Elucidating the Role of Phosphorylation by Polo like kinases in Modulating Alpha...
Elucidating the Role of Phosphorylation by Polo like kinases in Modulating Alpha Synuclein Aggregation and Toxicity in Parkinson s disease and Related Disorders
Increasing evidence suggest that alpha-synuclein (a-syn) phosphorylation plays an important role in the regulation of a-syn aggregation, Lewy Bodies (LBs) formation and neurotoxicity in Parkinson’s disease (PD) and related synucle...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
SAF2011-22643
RESPUESTA AL STRESS Y PROTEOSTASIS DE ALFA-SINUCLEINA EN LA...
36K€
Cerrado
MODIFYPD
Effects of posttranslational modifications of alpha synuclei...
180K€
Cerrado
NEURASYNC
Academic Industrial Training Network on Alpha Synuclein rela...
2M€
Cerrado
BFU2012-39737
MECANISMOS DE NEURODEGENERACION DEPENDIENTES DE ALFA-SINUCLE...
35K€
Cerrado
SAF2009-11292
MECANISMO DE LA FUNCION DE PARKINA Y REGULACION DE SU AGREGA...
133K€
Cerrado
CHAPERONES IN ND
The Role of Molecular Chaperones in Parkinson s Disease
178K€
Cerrado
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
Increasing evidence suggest that alpha-synuclein (a-syn) phosphorylation plays an important role in the regulation of a-syn aggregation, Lewy Bodies (LBs) formation and neurotoxicity in Parkinson’s disease (PD) and related synucleopathies. However, the exact kinase(s) responsible for phosphorylating a-syn and the relationships between phosphorylation, a-syn fibrillogenesis, LB formation and cell death have not been fully elucidated. Preliminary data in our Laboratory have pointed out a Polo-Like Kinase family (Plks) as an interesting candidate for a-syn phosphorylation and modulating protein aggregation. To determine the relationship between the phosphorylation of a-syn by Plk family, protein aggregation and neurodegeneration, we plan to use an integrative approach combining in vitro and in vivo approaches. In the in vitro part, we seek to elucidate the role of phosphorylation by Plks in modulating a-syn aggregation in vitro and in primary cell culture. In the in vivo part, we plan to study the possible co-localization of Plks and phosphorylated and unphosphorylated a-syn in LBs inclusions in the brain of parkinsonians patients and animal models of PD. We also seek to evaluate the biochemical and functional consequences of co-delivering Plks and various modified forms of a-syn directly to the rodent brain. This proposal will give us the opportunity to better understand functional consequences of a-syn phosphorylation and mechanisms by which it contributes to neurotoxicity. That will allow us to identify new therapeutic targets of synucleopathies treatment.